Explore / Clinical trial
Clinical trial

PET Synaptogenesis After Psilocybin In DEpression Recovery

Washington University School of MedicineWithdrawnPhase 2Started Jul 1, 20230 enrolledUnited StatesNCT05601648

Abstract

Participants with depression will be given a single dose of psilocybin and supportive psychotherapy before, during, and after drug administration. Participants will undergo positron emission tomography (PET) imaging before and one week after psilocybin using a marker of synaptic density. This design allows us to assess the relationship between neurotrophic, and antidepressant effects produced by psilocybin.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

11C-UCB-JSV2AMajor Depressive DisorderAnhedonia

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.